IL-17A expression has been implicated in the pathogenesis of pulmonary fibrosis, chronic allograft rejection, fibrosis in orthotopic lung transplantation, myocardial fibrosis, and hepatitis-induced hepatic fibrosis (109, 110). Here, IL17A is linked to Hepatitis.